Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review

Date: August 8, 2017
Pages: 56
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: M0E60528133EN
Leaflet:

Download PDF Leaflet

Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review
Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Merck KGaA (Merck), a subsidiary of E. Merck KG, is a pharmaceutical and chemical company. It discovers, develops and manufactures prescription drugs to treat cancer, multiple sclerosis, and infertility and over-the-counter products for colds and pain; and develops liquid crystal mixtures, OLED materials and cosmetic active ingredients. The company also provides a wide range of products including lab water systems to gene editing tools, cell lines, antibodies and end-to-end systems. Merck serves healthcare, performance materials and life sciences markets. It has presence in Europe, North America, Asia-Pacific, Latin America and Middle East and Africa. Merck is headquartered in Darmstadt, Hesse, Germany.

Merck KGaA Key Recent Developments

Aug 08,2017: Merck and Baylor College of Medicine Advance Vaccine Development and Manufacturing for Neglected Diseases
Aug 03,2017: Q2 2017: Merck Sets Course for Future Growth
Aug 03,2017: Executive Board Changes at Merck
Aug 03,2017: European Patent Office to Grant Merck’s Patent Application for CRISPR Technology
Jul 21,2017: Merck Opens New Application Laboratory in Shanghai

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Merck KGaA - Key Facts
Merck KGaA - Key Employees
Merck KGaA - Key Employee Biographies
Merck KGaA - Major Products and Services
Merck KGaA - History
Merck KGaA - Company Statement
Merck KGaA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Merck KGaA - Business Description
Merck KGaA - Corporate Strategy
Merck KGaA - SWOT Analysis
SWOT Analysis - Overview
Merck KGaA - Strengths
Merck KGaA - Weaknesses
Merck KGaA - Opportunities
Merck KGaA - Threats
Merck KGaA - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Merck KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Merck KGaA, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 03, 2017: Q2 2017: Merck Sets Course for Future Growth
Aug 03, 2017: Executive Board Changes at Merck
Aug 03, 2017: European Patent Office to Grant Merck’s Patent Application for CRISPR Technology
Jul 21, 2017: Merck Opens New Application Laboratory in Shanghai
Jul 18, 2017: Merck uses Genedata Biologics to Scale-Up Bispecific Antibody Discovery Programs
Jul 12, 2017: Merck Refines Western European Life Science Production Site Network
Jul 06, 2017: Merck Biopharma Innovation Cup 2017
Jul 05, 2017: Merck Awards €1.25 Million to Research Projects Through its 2017 Grant for Fertility Innovation
Jul 05, 2017: Merck KGaA, Darmstadt, Germany Awards €1.25 Million to Research Projects Through its 2017 Grant for Fertility Innovation
Jun 29, 2017: Merck Expands Packaging Capacity at Swiss Biotech Manufacturing Site of Aubonne

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Merck KGaA, Key Facts
Merck KGaA, Key Employees
Merck KGaA, Key Employee Biographies
Merck KGaA, Major Products and Services
Merck KGaA, History
Merck KGaA, Subsidiaries
Merck KGaA, Key Competitors
Merck KGaA, Ratios based on current share price
Merck KGaA, Annual Ratios
Merck KGaA, Annual Ratios (Cont.1)
Merck KGaA, Annual Ratios (Cont.2)
Merck KGaA, Interim Ratios
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Merck KGaA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Merck KGaA, Performance Chart (2012 - 2016)
Merck KGaA, Ratio Charts
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Merck KGaA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Sanofi
Novartis AG
NewLink Genetics Corp
GlaxoSmithKline Plc
Eli Lilly and Company
BASF SE
AstraZeneca Plc
Skip to top


Ask Your Question

Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: